Literature DB >> 25388815

Which biotech foods are most acceptable to the public?

Jayson L Lusk1, Brandon R McFadden, Bradley J Rickard.   

Abstract

New discoveries are prompting questions about which types of genetically engineered foods and applications are likely to be most accepted by the public. Results of a survey of over 1000 US consumers reveals that people prefer eating beef to eating corn or apples if the foods are not genetically engineered, but exactly the opposite is true if the foods are genetically engineered. Eating fresh food is preferred to processed, but much less so if both food types are genetically engineered. Desirability of genetic engineering depends on the reason for the biotechnology application.
Copyright © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Year:  2014        PMID: 25388815     DOI: 10.1002/biot.201400561

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  4 in total

1.  Dissuasive effect, information provision, and consumer reactions to the term 'Biotechnology': The case of reproductive interventions in farmed fish.

Authors:  Micaela M Kulesz; Torbjörn Lundh; Dirk-Jan De Koning; Carl-Johan Lagerkvist
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

2.  Canadian Consumer Preferences Regarding Gene-Edited Food Products.

Authors:  Oswaldo Vasquez; Hayley Hesseln; Stuart J Smyth
Journal:  Front Genome Ed       Date:  2022-04-11

Review 3.  Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan.

Authors:  Armin Spök; Thorben Sprink; Andrew C Allan; Tomiko Yamaguchi; Christian Dayé
Journal:  Front Genome Ed       Date:  2022-08-31

4.  Information and order of information effects on consumers' acceptance and valuation for genetically modified edamame soybean.

Authors:  Ji Yong Lee; Michael P Popp; Elijah J Wolfe; Rodolfo M Nayga; Jennie S Popp; Pengyin Chen; Han-Seok Seo
Journal:  PLoS One       Date:  2018-10-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.